Research - May 2016 Archives

ROCHESTER, Minn. — “OB Nest”: Just the name may bring warm feelings to parents and prospective parents. However, at Mayo Clinic, it’s much more ...

SAN DIEGO ­ — A congenital condition called pectus excavatum, in which a child’s breastbone is sunken into the chest, can be corrected through minimally ...

ROCHESTER, Minn. — The Mayo Clinic Center for Individualized Medicine joined the National Microbiome Initiative sponsored by the White House Office of Science and ...

ROCHESTER, Minn. – The World Obesity Federation, representing scientific and medical obesity research globally, has named Michael Jensen, M.D., a Mayo Clinic endocrinologist and ...

ROCHESTER, Minn. — Discovery’s Edge, Mayo Clinic’s research magazine, is now available online in Spanish at http://discoverysedge.mayo.edu/espanol/ Each year, Mayo Clinic cares for more ...

Bridget Clausen refers to her seven grandchildren and three great-grandchildren as "the love of my life." She treasures each of them and is proud to have a great-granddaughter named after her. The joy of a namesake is especially sweet, because when Bridget learned her granddaughter was pregnant, she wasn't sure she would be here to meet the baby. At that time, Bridget was being treated for melanoma that had spread to several places in her body. Her treatment choices were dwindling. She decided to go to Mayo Clinic in Rochester, Minnesota, to see if doctors could offer any other options. As a result of that visit, Bridget enrolled in a clinical trial of a new drug. It turned out to be the answer she needed. The drug, now available under the brand name Keytruda, was approved by the Food and Drug Administration  in December 2015 as a first-line treatment for advanced melanoma. Interestingly, the foundation of the drug's development began in a Mayo Clinic lab more than 15 years ago. In Bridget's case, it successfully shrunk her tumors and stopped the spread of cancer. It also gave her the opportunity to meet her new great-granddaughter. 

ROCHESTER, Minn. — A protein called Bim may hold the clue to which patients may be successful on immunotherapy for metastatic melanoma, according to the ...

ROCHESTER, Minn. — A Mayo Clinic study suggests laboratory findings do not tell the whole story of how the diabetes drug metformin works to limit ...

PHOENIX — A Mayo Clinic research team, led by neurologists Todd Schwedt, M.D. and David Dodick, M.D., has been approved for $7 million in funding ...

The term “teamwork” is widely used when talking about scientific research, but when it comes to the Mayo Clinic version, it means cross-disciplinary teams ...